...
首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >Is superficial inguinal node dissection adequate for regional control of malignant melanoma in patients with N1 disease?
【24h】

Is superficial inguinal node dissection adequate for regional control of malignant melanoma in patients with N1 disease?

机译:N1病患者的腹股沟浅表淋巴结清扫术是否足以控制恶性黑色素瘤?

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The optimum extent of surgery for inguinal nodal metastases due to melanoma remains controversial. Recent evidence suggests a conservative superficial groin dissection (SGD) may provide adequate regional control. Aim: To evaluate patients with N1 stage disease treated with SGD to determine the recurrence rates and to evaluate whether SGD was adequate for regional control in these patients. Materials and methods: Patients undergoing SGD between April 2005 and April 2012 were retrospectively analysed from a prospectively collected database. Results: Sixty patients were treated by SGD of which 40 had palpable disease and 20 had a positive sentinel node. Overall median follow-up was 38 months, with median follow-up for the SNB group being 29 months and that of the PD group 49 months. Three patients (5%) developed groin recurrence following SGD. All patients recurred within the superficial site of surgery; there was no deep inguinal or pelvic recurrence. Distant recurrence occurred in 22 patients (36.7%), with 21 of these patients coming from the PD group and one from the SNB group. This difference was statistically significant (p < 0.05). Overall survival at 5 years was 70.3%. Survival at 5 years in the PD group was 63.8% and in the SNB group it was 90.9%, this difference was approaching significance (p = 0.08). Conclusion: SGD appears adequate for local disease control in patients with N1 sentinel node positive disease. Longer term followup for N1 palpable disease is required to determine the suitability of SGD for this group of patients.
机译:简介:对于因黑色素瘤引起的腹股沟淋巴结转移的最佳手术范围仍存在争议。最近的证据表明,保守的浅表腹股沟淋巴结清扫术(SGD)可能提供足够的区域控制。目的:评估接受SGD治疗的N1期疾病患者的复发率,并评估SGD是否足以进行这些患者的区域控制。材料和方法:从前瞻性收集的数据库中回顾性分析了2005年4月至2012年4月期间接受SGD的患者。结果:60例患者接受了SGD治疗,其中40例明显疾病,20例前哨淋巴结阳性。总体中位随访时间为38个月,SNB组中位随访时间为29个月,PD组中位随访时间为49个月。 SGD后三名患者(5%)出现腹股沟复发。所有患者均在手术浅表部位复发。没有腹股沟或骨盆深度复发。 22例患者(36.7%)发生远处复发,其中21例来自PD组,一名来自SNB组。这种差异具有统计学意义(p <0.05)。 5年总生存率为70.3%。 PD组的5年生存率为63.8%,SNB组为90.9%,这一差异接近显着性(p = 0.08)。结论:SGD似乎足以控制N1前哨淋巴结阳性患者的局部疾病。需要对N1可触及的疾病进行长期随访,以确定SGD是否适合该组患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号